<p class="title">Biotechnology major Biocon on Wednesday said it has received EU GMP certification for its sterile drug product manufacturing facility in Bengaluru.</p>.<p class="bodytext">The facility was inspected by the European agencies in March 2018, Biocon said in a filing to BSE.</p>.<p class="bodytext">"This facility is used for the manufacture of Biocon's portfolio of biosimilars," a company spokesperson said.</p>.<p class="bodytext">Earlier in May, in a regulatory filing Biocon had said it had received a preliminary report from the European Regulator post inspection of its sterile drug product facility in Bengaluru in March 2018.</p>.<p class="bodytext">"The report lists six major observations with no observation classified as critical. We will submit a corrective and preventive action plan to the European inspection agency within the stipulated time period," a company spokesperson had said.</p>
<p class="title">Biotechnology major Biocon on Wednesday said it has received EU GMP certification for its sterile drug product manufacturing facility in Bengaluru.</p>.<p class="bodytext">The facility was inspected by the European agencies in March 2018, Biocon said in a filing to BSE.</p>.<p class="bodytext">"This facility is used for the manufacture of Biocon's portfolio of biosimilars," a company spokesperson said.</p>.<p class="bodytext">Earlier in May, in a regulatory filing Biocon had said it had received a preliminary report from the European Regulator post inspection of its sterile drug product facility in Bengaluru in March 2018.</p>.<p class="bodytext">"The report lists six major observations with no observation classified as critical. We will submit a corrective and preventive action plan to the European inspection agency within the stipulated time period," a company spokesperson had said.</p>